A detailed history of Front Row Advisors LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 31 shares of LNTH stock, worth $3,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 31 -0.0%
Holding current value
$3,618
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023

BUY
$47.76 - $82.86 $1,337 - $2,320
28 Added 933.33%
31 $3,000
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $143 - $248
3 New
3 $3,000
Q2 2020

Aug 17, 2020

BUY
$10.34 - $15.51 $320 - $480
31 New
31 $0

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $8.02B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.